Nuclei Online is an Open Access publisher on the way to be the world leader in the provision of STM (Science, Technology and Medicine) Open Access content. As a publisher, Nuclei Online aims to disseminate knowledge and create an archive of literature for the field.
At Nuclei Online, we believe socializing the open access publishing model helps in accelerating scientific developments. You can interact with your fellow authors by visiting their profile page depending on their privacy settings.
Why Open Access?
Open Access is a publishing model which allows readers to access scientific publications online free of charge. Nuclei Online felicitates and encourages Open Access. Our aim is to spread knowledge and allow readers from around the world to contribute in building knowledge banks bypassing all the barriers.
ConnectLet your work reach to more people and access all your published articles at one place through Connect.
Editorial BoardReputed Scientists and Scholars on the Editorial Board..
Other Features IncludeQuick processing and publication. Provision to have a hard copy. Articles Translated in multiple languages to reach wider audience. Minimum Publication Charges. Provision for audio copy upon request to anyone.
Recently joined Editors
Dr. Christine Dufès, Senior Lecturer in Drug Delivery, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, United Kingdom. Journal: IJCRDDr. Omar Sued, Director, Clinical Research, FundacionHuesped, Argentina. Journal: IJARDr. Amani Abd EL-Hamid El-Basmy, Chairman, Epidemiology and Cancer registry unit, Kuwait cancer Control center. Ministry of health, Kuwait. Journal: IJCRDDr. Emina Malisic, Assistant Research Professor, Laboratory for Molecular genetics, Department of experimental oncology. Institute for Oncology and Radiology of Serbia, Serbia. Journal: IJCRDDr. Alejandro Sosnik, Assistant Professor, Department of Pharmaceutical Technology, University of Buenos Aires, Argentina. Journal: IJARDr. Chae-Ok Yun, Professor, Department of Bioengineering, College of Engineering, Hanyang University, Korea. Journal: IJCRDProf. Guy Storme, Head of Department, Radiation Oncology, UZ Brussel, Belgium. Journal: IJCRDDr. Ajay Goel, Director, Epigenetics and Cancer Prevention, Baylor Research Institute, Baylor University Medical Center, USA. Journal: IJCRDDr. Gurudutt N. Pendyala, Instructor, Developmental Neuroscience Department, Munroe-Meyer Institute, University of Nebraska Medical Center, USA. Journal: IJAR